Expression of IL-5 in Thymocytes/T Cells Leads to the Development of a Massive Eosinophilia, Extramedullary Eosinophilopoiesis, and Unique Histopathologies

Nancy A Lee, Michael P. McGarry, Kirsten A. Larson, Margaret A. Horton, Anne B. Kristensen, James J. Lee

Research output: Contribution to journalArticle

177 Citations (Scopus)

Abstract

Transgenic mice were generated using regulatory elements from the CD3δ gene to drive T cell expression of IL-5. Expression of this cytokine resulted in white blood cell counts that expand virtually unabated (∼400,000 cells/mm3). This expansion is characterized by a profound eosinophilia (>60%) and commensurate increases in the absolute numbers of all other white blood cell types. In particular, circulating B220+ B lymphocyte populations increased >30-fold over wild-type (+/+) levels. Cell differentials and expression studies using a marker for eosinophil precursor cells (major basic protein gene expression) suggest that the peripheral eosinophilia is induced primarily through the establishment of extramedullary sites of eosinophilopoiesis. These mice display a massive peritoneal cavity cell exudate (1-2 × 108 cells) dominated by eosinophils (∼50%) and the infiltration of eosinophils in nearly all organ systems. Sudden unexplained death occurs in 70% of all transgenic animals by 12 mo of age. Surviving transgenic animals display severe inflammatory pathologies that include ulcerating skin lesions as well as lower bowel inflammation. These pathologies parallel clinical observations of patients with a profound eosinophilia and imply that IL-5 effector functions during some inflammatory responses may be contingent upon peripheral lymphohemopoietic expression.

Original languageEnglish (US)
Pages (from-to)1332-1344
Number of pages13
JournalJournal of Immunology
Volume158
Issue number3
StatePublished - Feb 1 1997

Fingerprint

Interleukin-5
Eosinophilia
Thymocytes
T-Lymphocytes
Eosinophils
Genetically Modified Animals
Clinical Pathology
Peritoneal Cavity
Exudates and Transudates
Sudden Death
Leukocyte Count
Transgenic Mice
Leukocytes
B-Lymphocytes
Pathology
Cytokines
Inflammation
Gene Expression
Skin
Population

ASJC Scopus subject areas

  • Immunology

Cite this

Expression of IL-5 in Thymocytes/T Cells Leads to the Development of a Massive Eosinophilia, Extramedullary Eosinophilopoiesis, and Unique Histopathologies. / Lee, Nancy A; McGarry, Michael P.; Larson, Kirsten A.; Horton, Margaret A.; Kristensen, Anne B.; Lee, James J.

In: Journal of Immunology, Vol. 158, No. 3, 01.02.1997, p. 1332-1344.

Research output: Contribution to journalArticle

Lee, Nancy A ; McGarry, Michael P. ; Larson, Kirsten A. ; Horton, Margaret A. ; Kristensen, Anne B. ; Lee, James J. / Expression of IL-5 in Thymocytes/T Cells Leads to the Development of a Massive Eosinophilia, Extramedullary Eosinophilopoiesis, and Unique Histopathologies. In: Journal of Immunology. 1997 ; Vol. 158, No. 3. pp. 1332-1344.
@article{dd1cc3409899476593c6b78d7ff91223,
title = "Expression of IL-5 in Thymocytes/T Cells Leads to the Development of a Massive Eosinophilia, Extramedullary Eosinophilopoiesis, and Unique Histopathologies",
abstract = "Transgenic mice were generated using regulatory elements from the CD3δ gene to drive T cell expression of IL-5. Expression of this cytokine resulted in white blood cell counts that expand virtually unabated (∼400,000 cells/mm3). This expansion is characterized by a profound eosinophilia (>60{\%}) and commensurate increases in the absolute numbers of all other white blood cell types. In particular, circulating B220+ B lymphocyte populations increased >30-fold over wild-type (+/+) levels. Cell differentials and expression studies using a marker for eosinophil precursor cells (major basic protein gene expression) suggest that the peripheral eosinophilia is induced primarily through the establishment of extramedullary sites of eosinophilopoiesis. These mice display a massive peritoneal cavity cell exudate (1-2 × 108 cells) dominated by eosinophils (∼50{\%}) and the infiltration of eosinophils in nearly all organ systems. Sudden unexplained death occurs in 70{\%} of all transgenic animals by 12 mo of age. Surviving transgenic animals display severe inflammatory pathologies that include ulcerating skin lesions as well as lower bowel inflammation. These pathologies parallel clinical observations of patients with a profound eosinophilia and imply that IL-5 effector functions during some inflammatory responses may be contingent upon peripheral lymphohemopoietic expression.",
author = "Lee, {Nancy A} and McGarry, {Michael P.} and Larson, {Kirsten A.} and Horton, {Margaret A.} and Kristensen, {Anne B.} and Lee, {James J.}",
year = "1997",
month = "2",
day = "1",
language = "English (US)",
volume = "158",
pages = "1332--1344",
journal = "Journal of Immunology",
issn = "0022-1767",
publisher = "American Association of Immunologists",
number = "3",

}

TY - JOUR

T1 - Expression of IL-5 in Thymocytes/T Cells Leads to the Development of a Massive Eosinophilia, Extramedullary Eosinophilopoiesis, and Unique Histopathologies

AU - Lee, Nancy A

AU - McGarry, Michael P.

AU - Larson, Kirsten A.

AU - Horton, Margaret A.

AU - Kristensen, Anne B.

AU - Lee, James J.

PY - 1997/2/1

Y1 - 1997/2/1

N2 - Transgenic mice were generated using regulatory elements from the CD3δ gene to drive T cell expression of IL-5. Expression of this cytokine resulted in white blood cell counts that expand virtually unabated (∼400,000 cells/mm3). This expansion is characterized by a profound eosinophilia (>60%) and commensurate increases in the absolute numbers of all other white blood cell types. In particular, circulating B220+ B lymphocyte populations increased >30-fold over wild-type (+/+) levels. Cell differentials and expression studies using a marker for eosinophil precursor cells (major basic protein gene expression) suggest that the peripheral eosinophilia is induced primarily through the establishment of extramedullary sites of eosinophilopoiesis. These mice display a massive peritoneal cavity cell exudate (1-2 × 108 cells) dominated by eosinophils (∼50%) and the infiltration of eosinophils in nearly all organ systems. Sudden unexplained death occurs in 70% of all transgenic animals by 12 mo of age. Surviving transgenic animals display severe inflammatory pathologies that include ulcerating skin lesions as well as lower bowel inflammation. These pathologies parallel clinical observations of patients with a profound eosinophilia and imply that IL-5 effector functions during some inflammatory responses may be contingent upon peripheral lymphohemopoietic expression.

AB - Transgenic mice were generated using regulatory elements from the CD3δ gene to drive T cell expression of IL-5. Expression of this cytokine resulted in white blood cell counts that expand virtually unabated (∼400,000 cells/mm3). This expansion is characterized by a profound eosinophilia (>60%) and commensurate increases in the absolute numbers of all other white blood cell types. In particular, circulating B220+ B lymphocyte populations increased >30-fold over wild-type (+/+) levels. Cell differentials and expression studies using a marker for eosinophil precursor cells (major basic protein gene expression) suggest that the peripheral eosinophilia is induced primarily through the establishment of extramedullary sites of eosinophilopoiesis. These mice display a massive peritoneal cavity cell exudate (1-2 × 108 cells) dominated by eosinophils (∼50%) and the infiltration of eosinophils in nearly all organ systems. Sudden unexplained death occurs in 70% of all transgenic animals by 12 mo of age. Surviving transgenic animals display severe inflammatory pathologies that include ulcerating skin lesions as well as lower bowel inflammation. These pathologies parallel clinical observations of patients with a profound eosinophilia and imply that IL-5 effector functions during some inflammatory responses may be contingent upon peripheral lymphohemopoietic expression.

UR - http://www.scopus.com/inward/record.url?scp=0031068013&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0031068013&partnerID=8YFLogxK

M3 - Article

C2 - 9013977

AN - SCOPUS:0031068013

VL - 158

SP - 1332

EP - 1344

JO - Journal of Immunology

JF - Journal of Immunology

SN - 0022-1767

IS - 3

ER -